Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Myelodysplastic syndrome, susceptibility to, 614286; MDS (Myelodysplastic syndrome) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
EBV/Lymphoproliferation GenePanel Mayo Clinic Laboratories Mayo Clinic United States | 35 | 25 |
|
GATA2 Gene, Full Gene Analysis Mayo Clinic Laboratories Mayo Clinic United States | 4 | 1 |
|
NGS Panel for Congenital and Acquired Sideroblastic Anemia BloodGenetics Spain | 18 | 17 |
|
Pittsburgh Cytogenetics Laboratory University of Pittsburgh Medical Center United States | 2 | 73 |
|
Genetic Pathology SA Pathology Australia | 1 | 1 |
|
Comprehensive HemeComplete Profile + Heme Fusion + CALR PCR + FLT3 PCR PathGroup United States | 16 | 160 |
|
UCSF Molecular Diagnostics Laboratory UCSF Molecular Diagnostics Laboratory University of California, San Francisco United States | 4 | 52 |
|
Centogene AG - the Rare Disease Company Germany | 156 | 107 |
|
Centogene AG - the Rare Disease Company Germany | 218 | 135 |
|
Centogene AG - the Rare Disease Company Germany | 74 | 34 |
|
GATA2 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 4 | 1 |
|
GNB1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 3 | 1 |
|
SF3B1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
ASXL1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.